Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms

International Journal of Clinical Practice

Volumn 67, Issue 4, 2013, Pages 342-350

  Brubaker, L ^a   Piault, E C ^b   Tully, S E ^b   Evans, C J ^b   Bavendam, T ^c   Beach, J ^d   Yeh, Y ^b   Kopp, Z S ^c   Khullar, V ^e   Kelleher, C J ^f   Trocio, J ^c  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b MAPI VALUES   (United States)

^c PFIZER INC   (United States)

^d Beach Clinical Studies   (United States)

^e ST MARY S HOSPITAL   (United Kingdom)

^f ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONCURRENT VALIDITY; CONVERGENT VALIDITY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FACE VALIDITY; FEMALE; FOLLOW UP; GOAL ATTAINMENT; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF ASSESSMENT GOAL ACHIEVEMENT QUESTIONNAIRE; UNITED STATES; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE; VALIDATION STUDY; VALIDITY;

ACHIEVEMENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC SELF EVALUATION; FEMALE; GOALS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PERCEPTION; PROFESSIONAL-PATIENT RELATIONS; QUESTIONNAIRES; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; YOUNG ADULT;

EID: 84875519870     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12087     Document Type: Article

References (29)

1. Marschall-Kehrel D, Roberts RG, Brubaker L,. Patient-reported outcomes in overactive bladder: the influence of perception of condition and expectation for treatment benefit. Urology 2006; 68 (Suppl. 2A): 29-37.
2. Rodriguez LV, Blander DS, Dorey F, et al., Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms. Urology 2003; 62: 49-53.
3. Chapple CR, Rosenberg MT, Brenes FJ,. Listening to the patient: a flexible approach to the use of antimuscarinic agents in overactive bladder syndrome. BJU Int 2009; 104: 960-7.
4. Kiresuk T, Sherman R,. Goal attainment scaling: a general method of evaluating comprehensive community mental health programs. Community Ment Health J 1968; 4: 443-53.
5. Ashford S, Turner-Stokes L,. Goal attainment for spasticity management using botulinum toxin. Physiother Res Int 2006; 11: 24-34.
6. Brubaker L, Khullar V, Piault E, et al., Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire. Int Urogynecol J 2011; 22: 937-46.
7. Fianu-Jonasson A, Brubaker L, Kelleher C, et al., Understanding Swedish patients' expectations for treatment of their urinary symptoms. Reykjavik, Iceland: Nordic Urogynecological Association, 2009.
8. Hullfish KL, Bovbjerg VE, Gibson J, Steers WD,. Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved?. Am J Obstet Gynecol 2002; 187: 88-92.
9. Mahajan ST, Elkadry EA, Kenton KS, et al., Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 2006; 194: 722-8.
10. Payne C, Allee T,. Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes. Neurourol Urodyn 2009; 28: 13-7.
11. US Department of Health and Human Services. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006; 4: 79.
12. Patrick DL, Burke LB, Gwaltney CJ, et al., Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health 2011; 14: 967-77.
13. Patrick DL, Burke LB, Gwaltney CJ, et al., Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2-assessing respondent understanding. Value Health 2011; 14: 978-88.
14. Diokno AC, Brock BM, Brown MB, Herzog AR,. Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 1986; 136: 1022-5.
15. Barber MD, Kuchibhatla MN, Pieper CF, Bump RC,. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 2001; 185: 1388-95.
16. Coyne K, Revicki D, Hunt T, et al., Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 2002; 11: 563-74.
17. Piault E, Evans CJ, Espindle D, et al., Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Neurourol Urodyn 2008; 27: 179-90.
18. Coyne KS, Matza LS, Kopp Z, Abrams P,. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol 2006; 49: 1079-86.
19. Hurst H, Bolton J,. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther 2004; 27: 26-35.
20. Coyne KS, Tubaro A, Brubaker L, Bavendam T,. Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts. Urology 2006; 68: 9-16.
21. Brubaker L, Kopp Z, Piault E, et al., Development of a Self-Assessment Goal Achievement (SAGA) questionnaire in urinary disorders. Rotterdam, The Netherlands: International Continence Society, 2007.
22. Elinoff V, Bavendam T, Glasser DB, et al., Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial. Int J Clin Pract 2006; 60: 745-51.
23. Abrams P, Artibani W, Gajewski JB, Hussain I,. Assessment of treatment outcomes in patients with overactive bladder: importance of objective and subjective measures. Urology 2006; 68 (Suppl. 2A): 17-28.
24. Coyne KS, Elinoff V, Gordon DA, et al., Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine. Int J Clin Pract 2008; 62: 925-31.
25. Van Kerrebroeck PE, Kelleher CJ, Coyne KS, et al., Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo. Health Qual Life Outcomes 2009; 7: 13.
26. Choo MS, Doo CK, Lee KS,. Satisfaction with tolterodine: assessing symptom-specific patient-reported goal achievement in the treatment of overactive bladder in female patients (STARGATE study). Int J Clin Pract 2008; 62: 191-6.
27. Cardillo JE, Smith A,. Psychometric issues. In:, Kiresuk TJ, Smith A, Cardillo JE, eds. Goal attainment scaling: applications, theory, and measurement. Hillside, NJ: Erlbaum, 1994: 173-212.
28. Clark MS, Caudrey DJ,. Evaluation of rehabilitation services: the use of goal attainment scaling. Int Rehabil Med 1983; 5: 41-5.
29. Forbes DA,. Goal Attainment Scaling. A responsive measure of client outcomes. J Gerontol Nurs 1998; 24: 34-40.